
Anterogen.Co.,Ltd.
065660.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
37.9%
Operating Income
-3
Operating Margin
-54.1%
Net Income
-2
Net Margin
-33.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-1
EBITDA Margin
-23.3%
2023
12/31/2023
Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
41.0%
Operating Income
-4
Operating Margin
-78.1%
Net Income
-2
Net Margin
-43.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-0
EBITDA Margin
-7.5%
2022
12/31/2022
Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
39.7%
Operating Income
-3
Operating Margin
-70.5%
Net Income
-5
Net Margin
-103.7%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-3
EBITDA Margin
-66.6%
2021
12/31/2021
Revenue
6
Cost of Revenue
3
Gross Profit
3
Gross Margin
47.7%
Operating Income
-2
Operating Margin
-32.3%
Net Income
-0
Net Margin
-6.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1
EBITDA Margin
20.0%
2020
12/31/2020
Revenue
3
Cost of Revenue
2
Gross Profit
1
Gross Margin
42.0%
Operating Income
-3
Operating Margin
-89.5%
Net Income
-3
Net Margin
-105.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-84.4%